Research progress in comprehensive evaluation methods of drugs

doi:10.19803/j.1672-8629.2022.07.25

Abstract

Abstract: With the deepening of health care reforms, amid refined pharmaceutical management by the state and medical institutions and along with patients' demand for precise pharmaceutical services, comprehensive drug evaluation has become imperative. The scientific and standardized comprehensive evaluation of drugs and the application of the results will provide data for the revision of the national drug-related catalogs and technical specifications, the rational clinical use of drugs in medical institutions, and for standardized management. By searching the literature related to comprehensive drug evaluation methods, the methods currently available at home and abroad are reviewed, and the characteristics and key elements of different methods are discussed so as to provide reference for the construction and improvement of a standardized comprehensive drug evaluation system in China.

Key words: comprehensive evaluation of drug, evaluation method for drug, pharmaceutical services

CLC Number:

R954

YANG Ping, LU Song, DONG Xianzhe, ZHANG Lan. Research progress in comprehensive evaluation methods of drugs[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 803-806.

References

[1] TAN ZX, XU P.Establishment of comprehensive drug evaluation system in China needs to be completed and further improvement[J]. Drug Evaluation(药品评价), 2011, 8(18): 4-5.
[2] ZHANG GJ, CHU XY, TIAN YJ, et al.Implication of EU pharma-covigilance system to China[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2015, 12(10): 593-596.
[3] LIU J, LI CL, GUO LH, et al.Research on system of post-marketing evaluation in Japan[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2017, 14(3): 158-160.
[4] LIU PY.Brief introduction to the post-marketing evaluation system of foreign drugs[J]. Shanghai Medical & Pharmaceutical Journal(上海医药), 2004, 12(5): 208-210.
[5] HE W.Concepts and types of re-evaluation of post-marketing drugs in China[J]. Central South Pharmacy(中南药学), 2015, 13(7): 780-782.
[6] China Drug Comprehensive Evaluation Guidelines Project Team. Guideline for comprehensive evaluation of medicine in China (2nd edition)[J].Drug Evaluation(药品评价), 2015, 12(8): 6.
[7] National Health Commission of the People's Republic of China.Notice on Carrying out Drug Use Monitoring and Clinical Comprehensive Evaluation[EB/OL].(2019-04-09)[2020-12-01]. http://www.nhc.gov.cn/cms-search/xxgk/getManuscriptXxgk.htm?id=31149bb1845e4c019a04f30c0d69c2c9.
[8] TIAN L, GUAN X, MA AX.Systematic comparison of randomized controlled trial study and observational study[J]. China Pharmacy(中国药房), 2018, 29(4): 493-496.
[9] HAN M, CHEN W, CAO HJ, et al.One of comparative effectiveness research: cohort study design[J]. Modern Chinese Clinical Medicine(现代中医临床), 2015, 22(3): 20-23.
[10] ZHOU JM.Improving national essential drug related work and pushing the development and implementation of national drug policies[J]. Chinese Pharmaceutical Affairs(中国药事), 2005(3): 3-5.
[11] TIAN L, FU LY, MA AX.Understanding of economic re-evaluation of Chinese drugs after market[J]. Herald of Medicine(医药导报), 2020, 39(6): 884-886.
[12] LIU GE.China Pharmacoeconomic Evaluation Guidelines (2020))(中国药物经济学评价指南(2020))[M]. Beijing: China Market Press, 2020.
[13] WU JH.Guideline for comprehensive evaluation of medicine in China (2nd edition) chapter 6 guidelines for economic evaluation of clinical drugs[J]. Drug Evaluation(药品评价), 2015, 12(8): 16-19.
[14] SHI XY, ZHAO R, LI F, et al.Reflections on the establishment of clinical comprehensive evaluation mechanism for drugs in China[J]. China Pharmacy(中国药房), 2020, 31(23): 2828-2833.
[15] JIA LL, MENG Y, LIU YW, et al.Evidence-based comprehensive pediatric drug evaluation involved with analytic hierarchy process[J]. Chinese Journal of Pharmacoepidemiology(药物流行病学杂志), 2016, 25(10): 601-605.
[16] LIU Q, ZHANG SY, LI HY, et al.Exploration of evidence-based and pharmacoeconomics theory applied in China essential medicine List[J]. Chinese Journal of Drug Evaluation(中国药物评价), 2016, 33(5): 452-456.
[17] SHI FH, GU ZC, CUI M.Application of delphi method in pharm-acy[J]. China Pharmacist(中国药师), 2016, 19(5): 985-987.
[18] SUN ZS.Drug evaluation heavy as Taishan[J]. Drug Evaluation(药品评价), 2010, 7(2): 26-29.
[19] SUN X, TAN J, TANG L, et al.Revisiting real-world study[J]. Chinese Journal of Evidence-Based Medicine(中国循证医学杂志), 2017, 17(2): 126-130.
[20] SUN X, TAN J, TANG L, et al.Real world evidence: experience and lessons from China[J]. BMJ, 2018, 360(2): j5262.